New drug combo trial offers hope for advanced breast cancer patients
NCT ID NCT06942234
Summary
This study is testing whether a new drug called JSKN016, when combined with other cancer treatments, can help control advanced breast cancer that has spread or cannot be removed by surgery. It will involve 180 Chinese adults whose cancer does not respond to the HER2 protein. Researchers will measure how well the tumors shrink and how safe the treatment combinations are for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INOPERABLE LOCALLY ADVANCED HER2-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer center
RECRUITINGShanghai, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.